当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析 - 现金流量表

药明康德

(603259)

  

流通市值:1197.50亿  总市值:1379.54亿
流通股本:25.46亿   总股本:29.33亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金39,358,491,885.829,156,882,495.5418,754,345,577.669,690,301,767.82
收到的税费返还1,687,206,830.411,335,873,478.1828,892,747.71571,241,488.56
收到其他与经营活动有关的现金1,227,127,258.491,070,091,927.36725,595,146.23173,767,553.63
经营活动现金流入的平衡项目0000
经营活动现金流入小计42,272,825,974.731,562,847,90120,308,833,471.610,435,310,810.01
购买商品、接受劳务支付的现金14,188,504,564.789,995,805,548.56,834,992,034.412,802,341,671.68
支付给职工以及为职工支付的现金10,692,458,333.048,258,283,939.095,836,313,105.773,261,063,233.59
支付的各项税费2,290,959,872.331,728,708,555.731,216,607,428.47754,318,861.22
支付其他与经营活动有关的现金1,713,991,425.781,263,261,998.11822,740,168.8590,257,785.34
经营活动现金流出的平衡项目0000
经营活动现金流出小计28,885,914,195.9321,246,060,041.4314,710,652,737.457,407,981,551.83
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额13,386,911,778.7710,316,787,859.575,598,180,734.153,027,329,258.18
二、投资活动产生的现金流量:
收回投资收到的现金2,600,266,757.051,444,052,430.091,056,060,150.2244,877,502.07
取得投资收益收到的现金283,060,487.95101,907,253.6685,864,890.314,498,533.73
处置固定资产、无形资产和其他长期资产收回的现金净额16,118,970.9111,071,989.619,885,089.072,466,675.43
投资活动现金流入的平衡项目0000
投资活动现金流入小计2,899,446,215.911,557,031,673.361,151,810,129.58251,842,711.23
购建固定资产、无形资产和其他长期资产支付的现金5,516,558,842.193,649,714,542.522,414,983,315.221,269,711,163.58
投资支付的现金4,921,329,148.423,667,190,618.13276,842,816.53182,920,906.53
取得子公司及其他营业单位支付的现金22,091,789.0122,091,789.0122,091,789.0122,091,789.01
投资活动现金流出的平衡项目0000
投资活动现金流出小计10,459,979,779.627,338,996,949.662,713,917,920.761,474,723,859.12
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-7,560,533,563.71-5,781,965,276.3-1,562,107,791.18-1,222,881,147.89
三、筹资活动产生的现金流量:
吸收投资收到的现金246,636,106.658,303,918.8434,999,066.048,664,590.1
取得借款收到的现金6,843,975,150.946,162,238,486.314,796,582,286.692,503,563,303.62
筹资活动现金流入平衡项目0000
筹资活动现金流入小计7,090,611,257.546,220,542,405.154,831,581,352.732,512,227,893.72
偿还债务支付的现金6,665,760,526.125,396,980,526.124,601,106,919.122,255,396,063.12
分配股利、利润或偿付利息支付的现金2,755,792,179.252,733,548,830.212,703,385,889.6237,501,548.79
支付其他与筹资活动有关的现金1,610,442,236.91,394,000,468.5143,031,153.5470,427,989.61
筹资活动现金流出平衡项目0000
筹资活动现金流出小计11,031,994,942.279,524,529,824.837,447,523,962.282,363,325,601.52
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-3,941,383,684.73-3,303,987,419.68-2,615,942,609.55148,902,292.2
四、汇率变动对现金及现金等价物的影响132,139,998.6231,612,284.73181,005,246.33-69,410,656.48
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额2,017,134,528.931,462,447,448.321,601,135,579.751,883,939,746.01
加:期初现金及现金等价物余额7,983,904,283.097,983,904,283.097,983,904,283.097,983,904,283.09
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额10,001,038,812.029,446,351,731.419,585,039,862.849,867,844,029.1
补充资料:
净利润9,700,260,033.27-5,356,896,235.84-
资产减值准备156,508,914.41-55,924,809.72-
固定资产和投资性房地产折旧1,901,596,119.09-910,512,119.4-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,901,596,119.09-910,512,119.4-
无形资产摊销157,861,503.22-78,438,061.28-
长期待摊费用摊销228,280,536.91-113,395,253.26-
处置固定资产、无形资产和其他长期资产的损失33,450,046.48-3,673,282.4-
固定资产报废损失11,778,692.16-2,686,548.64-
公允价值变动损失37,809,127.95--310,992,128.5-
财务费用13,223,055.73--335,258,883.55-
投资损失-233,848,997.4--320,222,656.01-
递延所得税232,560,344.31-50,683,410.9-
其中:递延所得税资产减少142,915,760.76-81,832,381.56-
递延所得税负债增加89,644,583.55--31,148,970.66-
存货的减少977,626,158.3-7,770,588.18-
经营性应收项目的减少-2,140,598,895.08--1,875,850,086.88-
经营性应付项目的增加1,058,302,166.39-1,236,041,541.71-
其他756,006,487.94-396,759,401.12-
现金的期末余额10,001,038,812.02-9,585,039,862.84-
减:现金的期初余额7,983,904,283.09-7,983,904,283.09-
公告日期2024-03-192023-10-312023-08-012023-04-25
审计意见(境内)标准无保留意见
TOP↑